The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefor comprising said analogues.

 
Web www.patentalert.com

< Method of treating a subject suffering stroke comprising administering Glucagon-like peptide-1 analogs

> Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof

> Sustained release GLP-1 receptor modulators

~ 00515